United States Nuclear Medicine/Radiopharmaceutic Market Report & Forecast 2021-2027

United States Nuclear Medicine/Radiopharmaceutic Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Nuclear Medicine/Radiopharmaceutic Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Nuclear Medicine/Radiopharmaceutic Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Nuclear Medicine/Radiopharmaceutic Overall Market Size
2.1 United States Nuclear Medicine/Radiopharmaceutic Market Size: 2021 VS 2027
2.2 United States Nuclear Medicine/Radiopharmaceutic Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Nuclear Medicine/Radiopharmaceutic Sales: 2016-2027
3 Company Landscape
3.1 Top Nuclear Medicine/Radiopharmaceutic Players in United States Market
3.2 Top United States Nuclear Medicine/Radiopharmaceutic Companies Ranked by Revenue
3.3 United States Nuclear Medicine/Radiopharmaceutic Revenue by Companies
3.4 United States Nuclear Medicine/Radiopharmaceutic Sales by Companies
3.5 United States Nuclear Medicine/Radiopharmaceutic Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Nuclear Medicine/Radiopharmaceutic Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Players in United States Market
3.8.1 List of Tier 1 Nuclear Medicine/Radiopharmaceutic Companies in United States
3.8.2 List of Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Nuclear Medicine/Radiopharmaceutic Market Size Markets, 2021 & 2027
4.1.2 Tc-99
4.1.3 I-123/131
4.1.4 In-111
4.1.5 Xe-133
4.1.6 Th-201
4.1.7 Ga-67
4.1.8 Other
4.2 By Type - United States Nuclear Medicine/Radiopharmaceutic Revenue & Forecasts
4.2.1 By Type - United States Nuclear Medicine/Radiopharmaceutic Revenue, 2016-2021
4.2.2 By Type - United States Nuclear Medicine/Radiopharmaceutic Revenue, 2022-2027
4.2.3 By Type - United States Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2016-2027
4.3 By Type - United States Nuclear Medicine/Radiopharmaceutic Sales & Forecasts
4.3.1 By Type - United States Nuclear Medicine/Radiopharmaceutic Sales, 2016-2021
4.3.2 By Type - United States Nuclear Medicine/Radiopharmaceutic Sales, 2022-2027
4.3.3 By Type - United States Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2016-2027
4.4 By Type - United States Nuclear Medicine/Radiopharmaceutic Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Nuclear Medicine/Radiopharmaceutic Market Size, 2021 & 2027
5.1.2 Diagnostic
5.1.3 Therapeutic
5.2 By Application - United States Nuclear Medicine/Radiopharmaceutic Revenue & Forecasts
5.2.1 By Application - United States Nuclear Medicine/Radiopharmaceutic Revenue, 2016-2021
5.2.2 By Application - United States Nuclear Medicine/Radiopharmaceutic Revenue, 2022-2027
5.2.3 By Application - United States Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2016-2027
5.3 By Application - United States Nuclear Medicine/Radiopharmaceutic Sales & Forecasts
5.3.1 By Application - United States Nuclear Medicine/Radiopharmaceutic Sales, 2016-2021
5.3.2 By Application - United States Nuclear Medicine/Radiopharmaceutic Sales, 2022-2027
5.3.3 By Application - United States Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2016-2027
5.4 By Application - United States Nuclear Medicine/Radiopharmaceutic Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Overview
6.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales and Revenue in United States Market (2016-2021)
6.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Product Description
6.1.5 GE Healthcare Recent Developments
6.2 Bracco Imaging
6.2.1 Bracco Imaging Corporation Information
6.2.2 Bracco Imaging Overview
6.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales and Revenue in United States Market (2016-2021)
6.2.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product Description
6.2.5 Bracco Imaging Recent Developments
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Overview
6.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales and Revenue in United States Market (2016-2021)
6.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product Description
6.3.5 Mallinckrodt Recent Developments
6.4 Lantheus Medical Imaging
6.4.1 Lantheus Medical Imaging Corporation Information
6.4.2 Lantheus Medical Imaging Overview
6.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales and Revenue in United States Market (2016-2021)
6.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product Description
6.4.5 Lantheus Medical Imaging Recent Developments
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Overview
6.5.3 Bayer Nuclear Medicine/Radiopharmaceutic Sales and Revenue in United States Market (2016-2021)
6.5.4 Bayer Nuclear Medicine/Radiopharmaceutic Product Description
6.5.5 Bayer Recent Developments
6.6 Jubilant Pharma
6.6.1 Jubilant Pharma Corporation Information
6.6.2 Jubilant Pharma Overview
6.6.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales and Revenue in United States Market (2016-2021)
6.6.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product Description
6.6.5 Jubilant Pharma Recent Developments
6.7 Nordion
6.7.1 Nordion Corporation Information
6.7.2 Nordion Overview
6.7.3 Nordion Nuclear Medicine/Radiopharmaceutic Sales and Revenue in United States Market (2016-2021)
6.7.4 Nordion Nuclear Medicine/Radiopharmaceutic Product Description
6.7.5 Nordion Recent Developments
6.8 Eli Lilly
6.8.1 Eli Lilly Corporation Information
6.8.2 Eli Lilly Overview
6.8.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales and Revenue in United States Market (2016-2021)
6.8.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Product Description
6.8.5 Eli Lilly Recent Developments
6.9 SIEMENS
6.9.1 SIEMENS Corporation Information
6.9.2 SIEMENS Overview
6.9.3 SIEMENS Nuclear Medicine/Radiopharmaceutic Sales and Revenue in United States Market (2016-2021)
6.9.4 SIEMENS Nuclear Medicine/Radiopharmaceutic Product Description
6.9.5 SIEMENS Recent Developments
6.10 China Isotope & Radiation
6.10.1 China Isotope & Radiation Corporation Information
6.10.2 China Isotope & Radiation Overview
6.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales and Revenue in United States Market (2016-2021)
6.10.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product Description
6.10.5 China Isotope & Radiation Recent Developments
6.11 Yantai Dongcheng Biochemicals
6.11.1 Yantai Dongcheng Biochemicals Corporation Information
6.11.2 Yantai Dongcheng Biochemicals Overview
6.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales and Revenue in United States Market (2016-2021)
6.11.4 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product Description
6.11.5 Yantai Dongcheng Biochemicals Recent Developments
7 United States Nuclear Medicine/Radiopharmaceutic Production Capacity, Analysis
7.1 United States Nuclear Medicine/Radiopharmaceutic Production Capacity, 2016-2027
7.2 Nuclear Medicine/Radiopharmaceutic Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Nuclear Medicine/Radiopharmaceutic Supply Chain Analysis
9.1 Nuclear Medicine/Radiopharmaceutic Industry Value Chain
9.2 Nuclear Medicine/Radiopharmaceutic Upstream Market
9.3 Nuclear Medicine/Radiopharmaceutic Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Nuclear Medicine/Radiopharmaceutic Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Nuclear Medicine/Radiopharmaceutic in United States Market
Table 2. Top Nuclear Medicine/Radiopharmaceutic Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Nuclear Medicine/Radiopharmaceutic Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Nuclear Medicine/Radiopharmaceutic Revenue Share by Companies, 2016-2021
Table 5. United States Nuclear Medicine/Radiopharmaceutic Sales by Companies, (Kiloton), 2016-2021
Table 6. United States Nuclear Medicine/Radiopharmaceutic Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Nuclear Medicine/Radiopharmaceutic Price (2016-2021) & (US$/Ton)
Table 8. Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
Table 9. List of Tier 1 Nuclear Medicine/Radiopharmaceutic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Tc-99
Table 12. Major Manufacturers of I-123/131
Table 13. By Type - United States Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2016-2021
Table 17. By Type - United States Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2022-2027
Table 18. By Application - United States Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2016-2021
Table 22. By Application - United States Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2022-2027
Table 23. GE Healthcare Corporation Information
Table 24. GE Healthcare Description and Major Businesses
Table 25. GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 26. GE Healthcare Nuclear Medicine/Radiopharmaceutic Product
Table 27. GE Healthcare Recent Developments
Table 28. Bracco Imaging Corporation Information
Table 29. Bracco Imaging Description and Major Businesses
Table 30. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 31. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product
Table 32. Bracco Imaging Recent Developments
Table 33. Mallinckrodt Corporation Information
Table 34. Mallinckrodt Description and Major Businesses
Table 35. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 36. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product
Table 37. Mallinckrodt Recent Developments
Table 38. Lantheus Medical Imaging Corporation Information
Table 39. Lantheus Medical Imaging Description and Major Businesses
Table 40. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 41. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product
Table 42. Lantheus Medical Imaging Recent Developments
Table 43. Bayer Corporation Information
Table 44. Bayer Description and Major Businesses
Table 45. Bayer Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 46. Bayer Nuclear Medicine/Radiopharmaceutic Product
Table 47. Bayer Recent Developments
Table 48. Jubilant Pharma Corporation Information
Table 49. Jubilant Pharma Description and Major Businesses
Table 50. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 51. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product
Table 52. Jubilant Pharma Recent Developments
Table 53. Nordion Corporation Information
Table 54. Nordion Description and Major Businesses
Table 55. Nordion Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 56. Nordion Nuclear Medicine/Radiopharmaceutic Product
Table 57. Nordion Recent Developments
Table 58. Eli Lilly Corporation Information
Table 59. Eli Lilly Description and Major Businesses
Table 60. Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 61. Eli Lilly Nuclear Medicine/Radiopharmaceutic Product
Table 62. Eli Lilly Recent Developments
Table 63. SIEMENS Corporation Information
Table 64. SIEMENS Description and Major Businesses
Table 65. SIEMENS Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 66. SIEMENS Nuclear Medicine/Radiopharmaceutic Product
Table 67. SIEMENS Recent Developments
Table 68. China Isotope & Radiation Corporation Information
Table 69. China Isotope & Radiation Description and Major Businesses
Table 70. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 71. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product
Table 72. China Isotope & Radiation Recent Developments
Table 73. Yantai Dongcheng Biochemicals Corporation Information
Table 74. Yantai Dongcheng Biochemicals Description and Major Businesses
Table 75. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 76. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product
Table 77. Yantai Dongcheng Biochemicals Recent Developments
Table 78. Nuclear Medicine/Radiopharmaceutic Production Capacity (Kiloton) of Key Manufacturers in United States Market, 2019-2021 (Kiloton)
Table 79. United States Nuclear Medicine/Radiopharmaceutic Capacity Market Share of Key Manufacturers, 2019-2021
Table 80. Nuclear Medicine/Radiopharmaceutic Market Opportunities & Trends in United States Market
Table 81. Nuclear Medicine/Radiopharmaceutic Market Drivers in United States Market
Table 82. Nuclear Medicine/Radiopharmaceutic Market Restraints in United States Market
Table 83. Nuclear Medicine/Radiopharmaceutic Raw Materials
Table 84. Nuclear Medicine/Radiopharmaceutic Raw Materials Suppliers in United States Market
Table 85. Typical Nuclear Medicine/Radiopharmaceutic Downstream
Table 86. Nuclear Medicine/Radiopharmaceutic Downstream Clients in United States Market
Table 87. Nuclear Medicine/Radiopharmaceutic Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Nuclear Medicine/Radiopharmaceutic Product Picture
Figure 2. Nuclear Medicine/Radiopharmaceutic Segment by Type
Figure 3. Nuclear Medicine/Radiopharmaceutic Segment by Application
Figure 4. United States Nuclear Medicine/Radiopharmaceutic Market Overview: 2020
Figure 5. United States Nuclear Medicine/Radiopharmaceutic Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Nuclear Medicine/Radiopharmaceutic Revenue, 2016-2027 (US$, Mn)
Figure 7. Nuclear Medicine/Radiopharmaceutic Sales in United States Market: 2016-2027 (Kiloton)
Figure 8. The Top 3 and 5 Players Market Share by Nuclear Medicine/Radiopharmaceutic Revenue in 2020
Figure 9. Tc-99 Product Picture
Figure 10. I-123/131 Product Picture
Figure 11. In-111 Product Picture
Figure 12. Xe-133 Product Picture
Figure 13. Th-201 Product Picture
Figure 14. By Type - United States Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2016-2027
Figure 15. By Type - United States Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2016-2027
Figure 16. By Type - United States Nuclear Medicine/Radiopharmaceutic Price (US$/Ton), 2016-2027
Figure 17. Diagnostic
Figure 18. Therapeutic
Figure 19. By Application - United States Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2016-2027
Figure 20. By Application - United States Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2016-2027
Figure 21. By Application - United States Nuclear Medicine/Radiopharmaceutic Price (US$/Ton), 2016-2027
Figure 22. GE Healthcare Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Bayer Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Nordion Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Eli Lilly Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. SIEMENS Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. United States Nuclear Medicine/Radiopharmaceutic Production Capacity (Kiloton), 2016-2027
Figure 34. Nuclear Medicine/Radiopharmaceutic Industry Value Chain
Figure 35. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs